Oral Anticoagulation in Patients with Chronic Liver Disease

The administration of an anticoagulant in patients with liver disease (nonalcoholic steatohepatitis—NASH, nonalcoholic fatty liver disease—NAFLD, chronic hepatitis, or cirrhosis) who have an indication (atrial fibrillation, venous thrombosis, or pulmonary embolism) is challenging because there is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Costache, Raluca S., Dragomirică, Andreea S., Gheorghe, Bogdan E., Balaban, Vasile D., Stanciu, Silviu M., Jinga, Mariana, Costache, Daniel O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967228/
https://www.ncbi.nlm.nih.gov/pubmed/36837547
http://dx.doi.org/10.3390/medicina59020346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967228/
https://www.ncbi.nlm.nih.gov/pubmed/36837547
http://dx.doi.org/10.3390/medicina59020346

Ejemplares similares